CJ, L., & YY, T. (2016). Axial length, refraction, and retinal vascularization 1 year after ranibizumab or bevacizumab treatment for retinopathy of prematurity. Dove Medical Press.
Style de citation Chicago (17e éd.)CJ, Lin, et Tsai YY. Axial Length, Refraction, and Retinal Vascularization 1 Year After Ranibizumab or Bevacizumab Treatment for Retinopathy of Prematurity. Dove Medical Press, 2016.
Style de citation MLA (8e éd.)CJ, Lin, et Tsai YY. Axial Length, Refraction, and Retinal Vascularization 1 Year After Ranibizumab or Bevacizumab Treatment for Retinopathy of Prematurity. Dove Medical Press, 2016.
Attention : ces citations peuvent ne pas être correctes à 100%.